Peter Attia· MD
and of course I think that trial is what was the catalyst for Amgen Sanofi and these other companies to start working on these drugs
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and of course I think that trial is what was the catalyst for Amgen Sanofi and these other companies to start working on these drugs
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
at least one of them has now become I think the most powerful drug we have on the market right which is the pcsk9 mutation
and interestingly at least one of them has now become I think the most powerful drug we have on the market right which is the pcsk9 mutation